189955-91-7

Usage

General Description

2-(Pentan-3-yloxy)acetic acid is a compound with the molecular formula C8H16O3. It is a derivative of acetic acid, with a pentan-3-yloxy group attached to the second carbon of the acetic acid molecule. This chemical is commonly used in organic synthesis and as a building block for the preparation of various pharmaceuticals and agrochemicals. It has also been studied for its potential use as a precursor in the production of specialty chemicals and as a reagent in organic reactions. Additionally, 2-(Pentan-3-yloxy)acetic acid has been investigated for its potential biological activity and pharmacological properties. Overall, 2-(PENTAN-3-YLOXY)ACETIC ACID has a range of potential applications in the fields of chemistry, pharmaceuticals, and biotechnology.

Upstream product

• 584-02-1 2-pentanol 
• 79-08-3 bromoacetic acid 
• 3926-62-3 sodium monochloroacetic acid 

Downstream Products

• 1344715-84-9 (S)-4-benzyl-3-(2-(pent-3-yloxy)acetyl)oxazolidin-2-one 
• 1344715-86-1 ethyl (4S,5R,6S)-7-((S)-4-benzyl-2-oxooxazolidin-3-yl)-4-((tert-butoxycarbonyl)amino)-5-hydroxy-7-oxo-6-(pentan-3-yloxy)heptanoate 
• 1344715-87-2 tert-butyl (4S,5R)-5-((S)-2-((S)-4-benzyl-2-oxooxazolidin-3-yl)-2-oxo-1-(pentan-3-yloxy)ethyl)-4-(3-ethoxy-3-oxopropyl)-2,2-dimethyloxazolidine-3-carboxylate 
• 1344715-82-7 ethyl (3R,4R,5S)-5-((tert-butoxycarbonyl)amino)-4-hydroxy-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate 

Relevant academic research and scientific papers

An aldol approach to the enantioselective synthesis of (-)-oseltamivir phosphate

A formal asymmetric synthesis of the antiviral agent (-)-oseltamivir phosphate is achieved using two aldol reactions as key steps.

Azide-free synthesis of oseltamivir from L-methionine

Highly enantioselective synthesis of oseltamivir has been achieved starting from L-methionine, in which Staudinger reaction is utilized for the alignment of three contiguous chiral centers of oseltamivir. The present method would lead to an alternative sy

BENZIMIDAZOLE DERIVATIVES

This invention relates to the compounds represented by a general formula [I]: ???[in which A1 and A2 represent optionally fluorine-substituted methine or the like; B represents halogen, cyano, lower alkyl or the like; D represents optionally substituted heterocyclic group or the like; and G represents C3-C20 aliphatic group such as alicyclic group]. These compounds inhibit nociceptin activities due to their high affinity to nociceptin receptor, and are useful as analgesic, antiobestic, corebral function improver, drugs for treatment of alzheimer's disease and dementia, remedies for schizophrenia and neurodegenerative diseases, antidepressant, remedies for diabetes insipidus, polyuria, hypotension and so on.

SAR in the alkoxy lactone series: The discovery of DFP, a potent and orally active COX-2 inhibitor

Extensive SAR has been established in the alkoxy lactone series and this has lead to the discovery of DFP (5,5-dimethyl-3-(2-propoxy)-4- methanesulfonylphenyl)-2(5H)-furanone), a potent COX-2 inhibitor exhibiting in vivo efficacy in all models studied.